Hemangiol

Hemangiol is a prescription oral product that contains the active ingredient propranolol hydrochloride. It is marketed in the European Union and is supplied as an oral formulation, though specific tablet strength is not disclosed. As a non‑selective beta‑adrenergic receptor blocker, Hemangiol works by inhibiting β1 and β2 receptors, affecting heart rate, contractility, and angiogenic pathways in certain vascular lesions.

Hemangiol is indicated for several cardiovascular and vascular conditions, based on its beta‑blocker activity. It is commonly prescribed for:

- Infantile hemangioma, to reduce lesion growth and promote regression - Hypertension, as part of blood pressure management - Angina pectoris, to decrease myocardial oxygen demand - Cardiac arrhythmias, for rate control in supraventricular tachycardia - Off‑label use in migraine prophylaxis under specialist supervision

Side effects of Hemangiol vary in frequency and severity. Patients should be aware of both common and serious reactions.

Common: - Fatigue or tiredness - Dizziness, especially when standing quickly - Cold extremities or reduced peripheral circulation - Gastrointestinal upset such as nausea or abdominal discomfort - Sleep disturbances or vivid dreams

Serious: - Marked bradycardia or heart block - Severe hypotension - Bronchospasm in patients with asthma - Hypoglycemia unawareness in diabetic patients - Mood changes or depression

Before starting Hemangiol, certain precautions should be considered to ensure safe use.

- Assess cardiovascular status, especially for bradycardia or heart block - Evaluate respiratory conditions, as asthma may worsen - Monitor blood glucose in diabetic patients, as beta‑blockade can mask hypoglycemia symptoms - Use cautiously in patients with severe peripheral vascular disease - Review liver and kidney function periodically - Discuss pregnancy and lactation status with a healthcare professional, as safety data are limited

Hemangiol can interact with several drug classes; some combinations should be avoided while others require careful monitoring.

Avoid: - Other beta‑blockers or calcium‑channel blockers that may cause additive cardiac depression - Non‑selective alpha agonists such as clonidine, which can exacerbate hypotension - Certain anti‑arrhythmic agents (e.g., amiodarone) that increase plasma propranolol levels

Use with caution: - Antidiabetic medications, due to potential masking of hypoglycemia - NSAIDs, which may reduce antihypertensive efficacy - Antidepressants (e.g., SSRIs) that can affect heart rate - Inhaled bronchodilators, as beta‑blockade may diminish their effect